SCHEMBL13359265

SCHEMBL13359265

COCCNc1ccc(C(=O)Nc2cccc3c2SC(C(=O)Nc2cc(C(C)(C)C)ccc2OC)C3)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HCAR3 P49019 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ NR1H4 Q96RI1 1/20 0.41
▸ LYN P07948 1/20 0.40
▸ MAPK9 P45984 1/20 0.40
▸ HTT P42858 3/20 0.40
▸ DHODH Q02127 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13797973 0.79 LYN (0.58) KMT2AMEN1POLBCYP1A2CYP3A4
SCHEMBL13359289 0.72 LYN (0.60) KMT2AMEN1POLBCYP1A2CYP3A4
SCHEMBL13797974 0.69 LYN (0.74) KMT2AMEN1POLBCYP1A2CYP3A4
SCHEMBL13359237 0.69 LYN (0.55) KMT2AMEN1POLBCYP1A2CYP3A4
SCHEMBL13797963 0.66 LYN (0.79) LYNMAPK9MAPK14
SCHEMBL14288429 0.63 CYP1A2 (0.63) KMT2AMEN1POLBCYP1A2CYP3A4
SCHEMBL2128183 0.62 HCAR3 (1.00) HCAR3ALDH1A1KDM4E
SCHEMBL4249317 0.62 HCAR3 (0.59) KMT2AMEN1POLBHCAR3ALDH1A1
SCHEMBL1542559 0.62 HCAR3 (0.43) CYP3A4HCAR3LYNMAPK9ALDH1A1
SCHEMBL24218510 0.61 HCAR3 (0.76) HCAR3ALDH1A1HDAC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497278-B1 HETEROCYCLIC AMIDE DERIVATIVES AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2010-05-26 — — EP disclosed
Send feedback